This question tests safe use of equipment and patient handling with patient-controlled analgesia pumps. The safety protocol requires monitoring for opioid-induced respiratory depression and intervening when respiratory rates fall below safe parameters. Assessing sedation/respirations and stopping the PCA per protocol while notifying the provider (B) addresses the immediate safety concern of respiratory depression (rate 10/min) in an opioid-naïve patient with continuous basal infusion. Having family activate PCA (A) bypasses safety mechanisms and increases overdose risk, changing settings without orders (C) exceeds nursing scope, and delaying intervention (D) risks further respiratory compromise. The decision-making principle is that respiratory rates below 12/min in opioid-naïve patients receiving PCA with basal rates constitute a medical emergency requiring immediate intervention. A transferable strategy is to recognize that continuous basal rates in opioid-naïve patients significantly increase overdose risk, and any signs of respiratory depression require immediate PCA cessation and provider notification.

This question tests safe use of equipment and patient handling when using continuous monitoring devices. The safety protocol requires ensuring proper sensor placement and signal quality while correlating readings with clinical assessment. Repositioning the pulse oximeter sensor and assessing waveform quality while verifying the reading with the client's condition (A) ensures accurate monitoring and appropriate clinical response to hypoxemia. Silencing alarms (B) delays intervention for a critical value, removing monitoring (C) eliminates continuous assessment needed for respiratory compromise, and delegating assessment to UAP (D) is inappropriate for interpreting abnormal values. The decision-making principle is that abnormal monitor readings require immediate verification of equipment function and correlation with clinical status before determining interventions. A transferable strategy is to always verify sensor placement and signal quality when monitors show concerning values, then assess whether the reading matches the client's clinical presentation before intervening.

This question tests safe use of equipment and patient handling regarding cardiac monitor alarm settings. The safety protocol requires individualizing alarm parameters based on the client's baseline vital signs to ensure clinically significant changes trigger alerts. Alarm limits set to 30-160/min (A) are too wide for a client with baseline 58-72/min and new beta-blocker therapy, potentially missing bradycardia or tachycardia requiring intervention. Using both telemetry and bedside monitoring (B) provides redundancy, proper electrode placement (C) ensures signal quality, and continuous display (D) enables ongoing assessment. The decision-making principle is that alarm parameters must be individualized to detect clinically significant changes while minimizing alarm fatigue. A transferable strategy is to set alarm limits 10-20% above and below the client's baseline parameters, with tighter limits for clients on new cardiac medications or with unstable conditions.

This question tests safe use of equipment and patient handling regarding IV pump programming for high-alert medications. The safety protocol requires accurate pump programming that matches prescribed dosing, especially for vasoactive medications where errors can cause immediate harm. The pump rate set to 60 mL/hr instead of 6 mL/hr (B) represents a 10-fold overdose of norepinephrine that requires immediate correction to prevent severe hypertension and potential stroke. Using a central line (A) is appropriate for vasoactive drugs, proper labeling (C) enhances safety, and enabled occlusion alarms (D) are standard safety features. The decision-making principle is that medication pump programming errors, particularly involving high-alert medications, require immediate intervention before patient harm occurs. A transferable strategy is to always verify pump settings against the order using independent double-checks and to recognize that rate programming errors are among the most dangerous equipment-related medication errors.

This question tests safe use of equipment and patient handling when programming IV pumps for secondary infusions. The safety protocol requires proper setup of secondary medications to prevent backflow and ensure accurate delivery. Ensuring the secondary tubing connects above the pump and hanging the secondary bag higher than the primary (A) prevents backflow and ensures the secondary medication infuses completely at the programmed rate. Adding filters (B) is unnecessary for this medication, increasing the primary rate (C) would result in fluid overload for a heart failure patient, and changing to IV push (D) eliminates the controlled delivery needed. The decision-making principle is that secondary IV setup must follow manufacturer guidelines to prevent medication errors and ensure complete drug delivery. A transferable strategy is to always verify proper secondary setup including connection point above the pump, appropriate height differential, and correct rate programming before initiating secondary infusions.

This question tests the safe use of equipment and patient handling. Safety protocols for nebulizers include avoiding smoking or flames due to fire risk with aerosolized medications. Instructing to avoid smoking and keep away from flames prevents fire hazards during treatments. Option B promotes overdosing; C underestimates cleaning needs; D advises improper positioning. The decision-making principle is to emphasize environmental safety. This protects against accidents. A transferable strategy is to assess home environments for hazards with all respiratory equipment.

This question tests the safe use of equipment and patient handling. Safety protocols for blood transfusions require stopping the infusion immediately for suspected reactions and maintaining access with saline. Stopping the transfusion, clamping tubing, and using saline ensures prompt response to potential hemolytic reaction. Option B slows but continues; C silences without stopping; D flushes with saline but continues. The decision-making principle is to halt infusions on adverse symptoms. This minimizes harm. A transferable strategy is to follow stop-and-assess protocols for all infusion reactions.

This question tests the safe use of equipment and patient handling. Safety protocols for telemetry require appropriate alarm limits tailored to the client's baseline and medications to detect changes promptly. Alarm limits set too wide require correction as they may miss bradycardia in a client on metoprolol. Option B is proper electrode placement; C shows standard display; D is safe transmitter use. The decision-making principle is to customize settings to individual needs. This ensures timely alerts. A transferable strategy is to adjust monitoring parameters based on client-specific data for all devices.

This question tests the safe use of equipment and patient handling. Safety protocols for PCA pumps prohibit proxy use to prevent oversedation, emphasizing client-only activation. Teaching the spouse to press only when the client reports pain ensures the client controls dosing, reducing overdose risk. Option B increases lockout, altering orders; C enables proxy use; D adds basal rate without order. The decision-making principle is to enforce client-controlled administration for safety. This protects against respiratory depression. A transferable strategy is to educate families on proper use of patient-activated devices to prevent misuse.

This question tests the safe use of equipment and patient handling. Safety protocols for capnography involve responding to elevated EtCO2 by assessing for hypoventilation and intervening accordingly. Assessing consciousness and breathing while stimulating deep breaths addresses potential opioid-induced hypoventilation promptly. Option B turns off alarms; C removes oxygen; D documents without action. The decision-making principle is to act on abnormal readings with clinical correlation. This ensures respiratory safety. A transferable strategy is to integrate waveform analysis with patient assessment in monitoring.